Cornea/External Disease News

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses the IC-8 Apthera IOL from AcuFocus, designed to correct up to 1.5 D of astigmatism.

NEW YORK — In a Healio Video Perspective from OSN New York, Aziz Mottiwala, of Tarsus Pharmaceuticals, discusses the FDA acceptance of the new drug application for TP-03 for the treatment of Demodex blepharitis.

The incidence of ocular trauma in pediatric patients may be higher than previously reported, according to a study presented at Real World Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Guillermo Amescua, MD, discusses his experience using ImprimisRx’s Fortisite, a compounded combination of tobramycin 1.5% and vancomycin 5%.

MONTEREY, Calif. — There is more than one way to treat neurotrophic keratopathy.

MILAN — At the ESCRS meeting, Farhad Hafezi, MD, PhD, speaks about a newly developed algorithm for cross-linking in thin corneas.

SAN DIEGO — A deep-learning model was able to predict patient demographics, clinical and subjective outcomes, and ocular surface health using meibography images, according to a study presented at Academy 2022.

SAN DIEGO — The use of the Prokera amniotic membrane can “generate clinical remission” of dry eye symptoms for at least 3 months, Scheffer C.G. Tseng, MD, PhD, said at Academy 2022.

Anything that happens to the eyelid will directly affect the eye’s surface. As a result, I cannot treat dry eye disease or any pathology on the surface without addressing the eyelids.

SAN DIEGO — Eyelid margin cleaning at an elevated controlled temperature reduced dry eye symptoms after 7 days in patients with meibomian gland dysfunction, according to a study presented at Academy 2022.